Hydrochloric Acid

Hydrochloric Acid

SCHEMBL133175

CCOC(=O)CNc1ccccc1.Cl

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 2/20 0.53
TOP2A known ✓ P11388 1/20 0.46
POLB P06746 1/20 0.59
PPID Q08752 1/20 0.54
ELANE P08246 1/20 0.51
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 1/20 0.47
MAPT P10636 5/20 0.46
LMNA P02545 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LTA4H P09960 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
RAB9A P51151 1/20 0.45
PIN1 Q13526 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62893 0.98 POLB (0.60) POLBPPIDGAAELANEALDH1A1
Alcohol SCHEMBL28628021 0.95 POLB (0.57) POLBPPIDGAAELANEALDH1A1
Acetic Acid SCHEMBL28661029 0.95 POLB (0.57) POLBPPIDGAAELANEALDH1A1
SCHEMBL11732203 0.93 POLB (0.56) POLBPPIDGAAELANEALDH1A1
Sulfuric Acid SCHEMBL28065986 0.92 POLB (0.55) POLBPPIDGAAELANEALDH1A1
Urethane SCHEMBL6105791 0.90 POLB (0.54) POLBPPIDGAAELANEALDH1A1
Urethane SCHEMBL7266227 0.90 POLB (0.54) POLBPPIDGAAELANEALDH1A1
Nitric Acid SCHEMBL27965379 0.89 POLB (0.52) POLBPPIDGAAELANEALDH1A1
SCHEMBL28250670 0.88 POLB (0.58) POLBPPIDGAAELANEALDH1A1
Hydrochloric Acid SCHEMBL27605421 0.87 GAA (0.47) POLBPPIDGAAELANEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4337352-A SALT FORMATION WITH OPTICALLY ACTIVE AMINE BAYER AKTIENGESELLSCHAFT (DE) 1982-06-29 US claimed
EP-0006187-B1 SEPARATION OF ENANTIOMERS OF CHIRAL CARBOXYLIC ACIDS BAYER AG (DE) 1980-12-10 EP claimed
EP-0006187-A1 Separation of enantiomers of chiral carboxylic acids BAYER AG (DE) 1980-01-09 EP claimed
CN-120041156-A Kerosene phase change material with solid-liquid thixotropic reversible conversion performance 中国科学院化学研究所 2025-05-27 CN disclosed
CN-118791431-A Dihydro-isoquinolone compounds and isoindoles Selective synthesis method of pinone compound 常州大学 2024-10-18 CN disclosed
CN-118359514-A N-ester salicylamide compound and preparation method and application thereof 湖南科技大学 2024-07-19 CN disclosed
CN-114409491-B Method for preparing trans-D-dichlorochrysanthemic acid by resolution of trans-dichlorochrysanthemic acid 中国科学院大连化学物理研究所 2023-02-21 CN disclosed
CN-114409491-A Method for preparing trans-D-dichlorochrysanthemic acid by resolution of trans-dichlorochrysanthemic acid 中国科学院大连化学物理研究所 2022-04-29 CN disclosed
CN-105603037-B Method for preparing cephalosporin by enzymatic acylation 天津大学 2020-07-31 CN disclosed
CN-108822133-A The method that cefalexin is separated in the reaction product of cefalexin is prepared from enzyme process 国药集团威奇达药业有限公司 2018-11-16 CN disclosed
CN-108822131-A The method of ampicillin is separated from the reaction product of enzyme process preparation ampicillin 国药集团威奇达药业有限公司 2018-11-16 CN disclosed
EP-0491477-A1 Pyridopyridazine compounds and their use Takeda Chemical Industries, Ltd. (JP) 1992-06-24 EP disclosed
US-4563477-A Process for the preparation of alpha-(N-pyrrolyl)-derivative acids, the salts and esters thereof; alpha-(N-pyrrolyl)-phenylacetic acids, the esters thereof, pharmaceutical compositions containing them and therapeutical applications thereof ANTIBIOTICOS, S.A. (ES) 1986-01-07 US disclosed
US-4385922-A Method of increasing the yield of legumes utilizing D- or DL-α-O,O-diethlyphosphorodithioylacetylphenylglycine ethyl esters STAUFFER CHEMICAL COMPANY (US) 1983-05-31 US disclosed
US-4337352-A SALT FORMATION WITH OPTICALLY ACTIVE AMINE BAYER AKTIENGESELLSCHAFT (DE) 1982-06-29 US disclosed
EP-0006187-B1 SEPARATION OF ENANTIOMERS OF CHIRAL CARBOXYLIC ACIDS BAYER AG (DE) 1980-12-10 EP disclosed
EP-0006187-A1 Separation of enantiomers of chiral carboxylic acids BAYER AG (DE) 1980-01-09 EP disclosed
US-4136180-A HYPOLIPIDEMIC SUBSTITUTED STYRENESULFONYLUREAS PFIZER INC. (US) 1979-01-23 US disclosed
US-4062960-A Hypolipidemic alkenesulfonamides PFIZER INC. (US) 1977-12-13 US disclosed
US-3983107-A ARTERIOSCLEROSIS PFIZER INC. (US) 1976-09-28 US disclosed